Elevance Health Stock Price To Earnings To Growth
| ELV Stock | USD 430.53 7.06 1.67% |
Elevance Health fundamentals help investors to digest information that contributes to Elevance Health's financial success or failures. It also enables traders to predict the movement of Elevance Stock. The fundamental analysis module provides a way to measure Elevance Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Elevance Health stock.
Elevance |
Elevance Health Company Price To Earnings To Growth Analysis
Elevance Health's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Current Elevance Health Price To Earnings To Growth | 0.92 X |
Most of Elevance Health's fundamental indicators, such as Price To Earnings To Growth, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Elevance Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
| Competition |
Based on the latest financial disclosure, Elevance Health has a Price To Earnings To Growth of 0.9229 times. This is 29.99% higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The price to earnings to growth for all United States stocks is 81.13% higher than that of the company.
Elevance Price To Earnings To Growth Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Elevance Health's direct or indirect competition against its Price To Earnings To Growth to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Elevance Health could also be used in its relative valuation, which is a method of valuing Elevance Health by comparing valuation metrics of similar companies.Elevance Health is currently under evaluation in price to earnings to growth category among its peers.
Elevance Fundamentals
| Return On Equity | 0.15 | ||||
| Return On Asset | 0.0509 | ||||
| Profit Margin | 0.03 % | ||||
| Operating Margin | 0.02 % | ||||
| Current Valuation | 119.22 B | ||||
| Shares Outstanding | 227.35 M | ||||
| Shares Owned By Insiders | 0.21 % | ||||
| Shares Owned By Institutions | 93.56 % | ||||
| Number Of Shares Shorted | 2.48 M | ||||
| Price To Earning | 19.27 X | ||||
| Price To Book | 2.33 X | ||||
| Price To Sales | 0.55 X | ||||
| Revenue | 176.81 B | ||||
| Gross Profit | 49.24 B | ||||
| EBITDA | 9.09 B | ||||
| Net Income | 5.97 B | ||||
| Cash And Equivalents | 7.39 B | ||||
| Cash Per Share | 150.32 X | ||||
| Total Debt | 31.23 B | ||||
| Debt To Equity | 0.66 % | ||||
| Current Ratio | 1.35 X | ||||
| Book Value Per Share | 181.62 X | ||||
| Cash Flow From Operations | 5.81 B | ||||
| Short Ratio | 1.71 X | ||||
| Earnings Per Share | 25.66 X | ||||
| Price To Earnings To Growth | 0.92 X | ||||
| Target Price | 494.29 | ||||
| Number Of Employees | 104.2 K | ||||
| Beta | 0.87 | ||||
| Market Capitalization | 97.13 B | ||||
| Total Asset | 116.89 B | ||||
| Retained Earnings | 33.55 B | ||||
| Annual Yield | 0.02 % | ||||
| Five Year Return | 1.13 % | ||||
| Net Asset | 116.89 B | ||||
| Last Dividend Paid | 6.52 |
About Elevance Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Elevance Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Elevance Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Elevance Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Elevance Stock Analysis
When running Elevance Health's price analysis, check to measure Elevance Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elevance Health is operating at the current time. Most of Elevance Health's value examination focuses on studying past and present price action to predict the probability of Elevance Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elevance Health's price. Additionally, you may evaluate how the addition of Elevance Health to your portfolios can decrease your overall portfolio volatility.